Marcus F, Fontaine G, Guiraud G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384-98. doi:10.1161/01.cir.65.2.384..
DOI: 10.1161/01.cir.65.2.384

Fontaine G, Guiraudon G, Frank R, et al. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: H. K, editor. Reentrant Arrhythmias. Lancaster: MTP Publishers; 1977;33450.

Richard G, Bennett I, Haris M, et al. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ ALVC or Both? Heart and lung Circ. 2019;28(1):164-77. doi:10.1016/j.hlc.2018.10.013..
DOI: 10.1016/j.hlc.2018.10.013

Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardio myopathy: The Padua criteria. Int J Cardiol. 2020;319:10614. doi:10.1016/j.ijcard.2020.06.005..
DOI: 10.1016/j.ijcard.2020.06.005

Towbin J, McKenna W, Abrams D, et al. HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear Rhythm. 2019;16(11):30172. doi:10.1016/j.hrthm.2019.05.007..
DOI: 10.1016/j.hrthm.2019.05.007

Arbelo E, Protonotarios A, Gimeno JR, 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(37):3503- 626. doi:10.1093/eurheartj/ehad194..
DOI: 10.1093/eurheartj/ehad194

Marcus F, McKenna W, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur Heart J. 2010;31(7):80614. doi:10.1093/eurheartj/ehq025..
DOI: 10.1093/eurheartj/ehq025

Алексеева Д.Ю., Кофейникова О.А., Марапов Д.И., Васичкина Е.С. Клинические особенности различных фенотипических форм аритмогенной кардиомиопатии в педиатрической популяции: систематический обзор и метаанализ. Российский кардиологический журнал. 2022;27(4S):5146. doi:10.15829/1560-4071-2022-5146..
DOI: 10.15829/1560-4071-2022-5146

Krahn A, Wilde A, Calkins H, et al. Arrhythmogenic right ventricular cardiomyopathy. JACC Clinical Electrophysiology. 2022;8(4):533-53. doi:10.1016/j.jacep.2021.12.002..
DOI: 10.1016/j.jacep.2021.12.002

Sen-Chowdhry S, Morgan RD, Chambers JC, et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med. 2010;61:233-53. doi:10.1146/annurev.med.052208.130419..
DOI: 10.1146/annurev.med.052208.130419

McKenna W, Thiene G, Nava A.Diagnosis of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Task force of the working group myocardial and pericardial disease of the European society of cardiology. Br.Heart J. 1994;71:215-8.

Corrado D, Anastasakis A, Basso C.Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiology. 2024;395:131447. doi.10.1016/j.ijcard.2023.131447.

Шляхто Е.В. Кардиология. Национальное руководство. 2-е изд. М: ГЭОТАРМедиа, 2023. 816с. ISBN: 978-5-9704-7537-9.

Габрусенко С., Гудкова А., Козиолова Н. и др. Гипертрофическая кардиомиопатия. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(5):4541. doi:10.15829/1560-4071-2021-4541..
DOI: 10.15829/1560-4071-2021-4541

Терещенко С., Галявич А., Ускач Т и др. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083. doi:10.15829/1560-4071-2020-4083..
DOI: 10.15829/1560-4071-2020-4083

Couto M, Souto M, Martínez A, et al. Accuracy of right ventricular volume and function assessed with cardiovascular magnetic resonance: comparison with echocardiographic parameters. Clin Imaging. 2020;59(1):61-7. doi:10.1016/j.clinimag.2019.10.002..
DOI: 10.1016/j.clinimag.2019.10.002

Bluemke DA. ARVC: Imaging diagnosis is still in the eye of the beholder. J Am Coll Cardiol Img. 2011;4:288-91. doi:10.1016/j.jcmg.2011.01.007..
DOI: 10.1016/j.jcmg.2011.01.007

Petersen SE, Khanji MY, Plein S,, et al. European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Cardiovascular Im. 2019;20:1321-31. doi:10.1093/ehjci/jez232. Erratum in: Eur Heart J Cardiovasc Imaging. 2019;20(12):1331. doi:10.1093/ehjci/jez289..
DOI: 10.1093/ehjci/jez289

D'Ascenzi F, Anselmi F, Piu P, et al. Cardiac magnetic resonance normal reference values of biventricular size and function in male athlete's Heart. JACC: Cardiovasc Im. 2019;12:1755-65. doi:10.1016/j.jcmg.2018.09.021..
DOI: 10.1016/j.jcmg.2018.09.021

Natori S, Lai S, Finn JP, et al. Cardiovascular function in the multiethnic study of atherosclerosis: normal values by age, sex, and ethnicity. Am J Roentgenol. 2006;186:357- 65. doi:10.2214/AJR.04.1868..
DOI: 10.2214/AJR.04.1868

Malayeri A, Johnson W, Macedo R, et al. Cardiac cine MRI: quantification of the relationship between fast gradient echo and steady-state free precession for determination of myocardial mass and volumes. J Magn Reson Imaging. 2008;28:60-6. doi:10.1002/jmri.21405..
DOI: 10.1002/jmri.21405

Mewton N, Liu CY, Croisille P.Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57(8):891-903. doi:10.1016/j.jacc.2010.11.013..
DOI: 10.1016/j.jacc.2010.11.013

Bing Р, Duec МР. Myocardial fibrosis: why image, how to image and clinical implications. Heart. 2019;105:1832-40.

Голухова Е.З., Александрова С.А., Бердибеков Б.Ш. Прогностическая роль количественной оценки миокардиального фиброза по данным магнитно-резонансной томографии с отсроченным контрастированием при неишемических дилатационных кардиомиопатиях: систематический обзор и метаанализ. Российский кардиологический журнал. 2021;26(12):4776. doi:10.15829/1560-4071-2021-4776..
DOI: 10.15829/1560-4071-2021-4776

Perazzolo Marra MP, Cipriani A, Rizzo S, et al. Myocardial tissue characterization in arrhythmogenic cardiomyopathy: comparison between endomyocardial biopsy and cardiac magnetic resonance. JACC Cardiovasc Imaging. 2021;14(8):1675-8. doi:10.1016/J.JCMG.2021.02.015..
DOI: 10.1016/J.JCMG.2021.02.015

Marra MP, Rizzo S, Bauce B, et al. Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis. Herz. 2015;40:600- 6. doi:10.1007/s00059-015-4228-0..
DOI: 10.1007/s00059-015-4228-0

Segura-Rodríguez D, Bermúdez-Jiménez FJ, Carriel V, et al. Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study. Eur. Heart J.Cardiovasc. Imaging. 2020;21:378-86. doi:10.1093/ehjci/jez277..
DOI: 10.1093/ehjci/jez277

Marra MP, Leoni L, Bauce B, et al. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol. 2012;5:91-100. doi:10.1161/CIRCEP.111.964635..
DOI: 10.1161/CIRCEP.111.964635

Aquaro GD, Barison A, Todiere G.Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy. Am J Cardiol. 2016;118(11):1730-6. doi:10.1016/j.amjcard.2016.08.056..
DOI: 10.1016/j.amjcard.2016.08.056

Zghaib T, Te Riele A, James C, et al. Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias. J Cardiovasc Magn Reson. 2021;23:58. doi:10.1186/s12968-020-00702-3..
DOI: 10.1186/s12968-020-00702-3

Rastegar N, Burt JR, Corona-Villalobos CP, et al. Cardiac MRI results and potential diagnostic errors in patients tested for arrhythmogenic right ventricular cardiomyopathy. RadioGraphics. 2014;34:553-1570.

Aquaro GD, Todiere G, Strata E.Usefulness of india ink artifact in steady-state free precession pulse sequences for detection and quantification of intramyocardial fat. J Magnet Res Im. 2014;40(1):1-249. doi.10.1002/jmri.24335.

Haliot K, Dubes V, Constantin M, et al. A 3D high resolution MRI method for the visualization of cardiac fibro-fatty infiltrations. Sci Rep. 2021;11:9266. doi:10.1038/s41598-021-85774-6..
DOI: 10.1038/s41598-021-85774-6

Марченко Д., Александрова С., Глазкова Е. и др. Определение диапазона референсных значений нативного времени Т1-, Т2-релаксации миокарда параметрических карт в модификации MOLLY. Креативная кардиология. 2024;18(1):36-43. doi:10.24022/1997-3187-2..
DOI: 10.24022/1997-3187-2

Georgiopoulos G, Zampieri M, Molaro S, et al. Cardiac magnetic resonance in patients with ARVC and family members: the potential role of native T1 mapping. Int J Card Imaging. 2021;37:2037-47. doi:10.1007/s10554-021-02166-7..
DOI: 10.1007/s10554-021-02166-7

Bourfiss M, Prakken NHJ, van der Heijden JF, et al. Diagnostic value of native T1 mapping in arrhythmogenic right ventricular cardiomyopathy. JACC Cardiovasc Imaging. 2019; 12 (8 Pt 1):1580-2. doi:10.1016/j.jcmg.2019.01.023..
DOI: 10.1016/j.jcmg.2019.01.023

Лутохина Ю., Благова О., Шестак А. и др. Эволюция диагностических критериев аритмогенной кардиомиопатии правого желудочка и их применения в клинической практике. Российский кардиологический журнал. 2021;26(11):4593. doi:10.15829/1560-4071-2021-4593..
DOI: 10.15829/1560-4071-2021-4593

Tavora F, Zhang M, Franco M, et al. Distribution of biventricular disease in arrhythmogenic cardiomyopathy: an autopsy study. Hum Pathol. 2012;43(4):592-6. doi:10.1016/j.humpath.2011.06.014..
DOI: 10.1016/j.humpath.2011.06.014

Макаренко В., Шляппо М., Александрова С.Магнитно-резонансная визуализация аритмогенной дисплазии правого желудочка. Новости сердечно-сосудистой хирургии. 2019;(3):280-2. doi:10.24022/2588-0284-2019-3-4-280-282..
DOI: 10.24022/2588-0284-2019-3-4-280-282

Dong Z, Dai L, Song H.Incremental Diagnostic Value of Right Ventricular Strain Analysis in Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Heart Assoc. 2024;13(1):e031403. doi:10.1161/JAHA.123.031403..
DOI: 10.1161/JAHA.123.031403

Heermann P, Fritsch H, Koopmann M.Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC), right ventricular outflow-tract tachycardia (RVOT-VT). Clin Res Cardiol. 2019;108(10):1147-62. doi:10.1007/s00392-019-01450-w..
DOI: 10.1007/s00392-019-01450-w

Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2019;40:1850-8.

Bourfiss M, Prakken N, James C.Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy, European Heart Journal - Cardiovascular Im. 2023;24(1):98-107.

Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45(1):98-103. doi:10.1016/j.jacc.2004.09.053..
DOI: 10.1016/j.jacc.2004.09.053

Feliu E, Moscicki R, Carrillo L, et al. Importance of cardiac magnetic resonance findings in the diagnosis of left dominant arrythmogenic cardiomyopathy. Rev Esp Cardiol. 2020;73(11):885-92. English, Spanish. doi:10.1016/j.rec.2019.12.004..
DOI: 10.1016/j.rec.2019.12.004

Aquaro GD, De Luca A, Cappelletto C, et al. Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2020;75:2753-65. doi:10.1016/j.jacc.2020.04.023.techniques..
DOI: 10.1016/j.jacc.2020.04.023.techniques